Yuqin Yao

2.8k total citations · 2 hit papers
80 papers, 1.8k citations indexed

About

Yuqin Yao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuqin Yao has authored 80 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 18 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuqin Yao's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Peptidase Inhibition and Analysis (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Yuqin Yao is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Peptidase Inhibition and Analysis (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Yuqin Yao collaborates with scholars based in China, United States and Sweden. Yuqin Yao's co-authors include Tinghong Ye, Jinliang Yang, Manyu Zhao, Ben Zhang, Cailing Gan, Hongyao Liu, Shijie Zhou, Ying Lu, Zui Tan and Yongmei Xie and has published in prestigious journals such as PLoS ONE, Diabetes and Journal of Hazardous Materials.

In The Last Decade

Yuqin Yao

78 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting fibrosis: mechanisms and clinical trials

2022 296 citations Manyu Zhao, Liqun Wang et al. Signal Transduction and Targeted Therapy profile →
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy

2021 153 citations Zui Tan, Hongbao Sun et al. Frontiers in Cell and Developmental Biology profile →

Peers

Countries citing papers authored by Yuqin Yao

Since Specialization

Citations

This map shows the geographic impact of Yuqin Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqin Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqin Yao more than expected).

Fields of papers citing papers by Yuqin Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuqin Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqin Yao. The network helps show where Yuqin Yao may publish in the future.

Co-authorship network of co-authors of Yuqin Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yuqin Yao. A scholar is included among the top collaborators of Yuqin Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuqin Yao. Yuqin Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Haizao Yuhu decoction ameliorates silica-induced lung injury by inhibiting transforming growth factor-beta1/Smad pathway 2025 ·Journal of Ethnopharmacology ·(unknown), (unknown), (unknown), Liqun Wang, Xuxi Chen, Mengzhu Wang, (unknown), Yuqin Yao, Linshen Xie	0
2	Design, synthesis, and evaluation of a novel TRAIL-activated HDAC6 inhibitor for the treatment of pulmonary fibrosis 2024 ·Bioorganic & Medicinal Chemistry ·Ying Gao, (unknown), (unknown), Hao Cui, Xuxi Chen, Liqun Wang, Manyu Zhao, (unknown), Ling Zhang, Tinghong Ye, Yong Zhu, Yuqin Yao	3
3	Increased m6A-RNA methylation and demethylase FTO suppression is associated with silica-induced pulmonary inflammation and fibrosis 2023 ·Toxicology ·(unknown), Liqun Wang, (unknown), Manyu Zhao, Xuxi Chen, Donglei Sun, Ye Wang, (unknown), (unknown), (unknown), (unknown), Yuqin Yao	6
4	Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms 2023 ·Signal Transduction and Targeted Therapy ·Na Jia, Yunzhen Gao, Min Li, Yi Liang, Yuwen Li, (unknown), Shiqi Huang, Qing Lin, Xun Sun, Qin He, Yuqin Yao, Ben Zhang, Zhirong Zhang, Ling Zhang	87
5	Temporal relationship between sleep duration and obesity among Chinese Han people and ethnic minorities 2023 ·BMC Public Health ·(unknown), Min Chen, (unknown), Lisha Yu, (unknown), Huijie Cui, Ping Li, Jiaqiang Liao, Ben Zhang, Yuqin Yao, Zhenmi Liu, Xia Jiang, Tao Liu, Chenghan Xiao	2
6	Design and synthesis of 1H-benzo[d]imidazole selective HDAC6 inhibitors with potential therapy for multiple myeloma 2023 ·European Journal of Medicinal Chemistry ·(unknown), Liyuan Zhang, Xuxi Chen, (unknown), Hao Cui, (unknown), Shanshan Zhao, Liqun Wang, Xiaolan Su, Manyu Zhao, Mengzhu Wang, (unknown), Tao Lu, Yong‐Guan Zhu, Qing-Qing Zhou, Yuqin Yao	6
7	Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice 2023 ·Molecular Therapy — Nucleic Acids ·Zixiang Yan, Yuqin Yao, Luyao Li, (unknown), (unknown), Shenghai Zhang, Qingquan Xiao, (unknown), Erwei Zuo, Chunlong Xu, Jihong Wu, Hui Yang	14
8	Filamin A is overexpressed in non-alcoholic steatohepatitis and contributes to the progression of inflammation and fibrosis 2023 ·Biochemical and Biophysical Research Communications ·Ying Lü, Mengzhu Wang, Manyu Zhao, Qianru Zhang, Rui Qian, Zan Hu, Ke Qi, Lin Yu, Liqun Wang, Qinhuai Lai, Zhenmi Liu, Xia Jiang, Ben Zhang, Jinliang Yang, Yuqin Yao	5
9	Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish 2022 ·Disease Models & Mechanisms ·Xiaolin Ai, Zengpanpan Ye, (unknown), Jian Zhong, Joseph J. Lancman, (unknown), Xiangyu Pan, Yang Yu, (unknown), Xiang Wang, Shi H, (unknown), Yuqin Yao, Dan Cao, Chengjian Zhao	10
10	Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer 2022 ·European Journal of Medicinal Chemistry ·Hao Cui, (unknown), Yang Kang, (unknown), Yichao Wu, (unknown), Ran Wei, (unknown), Hui Wang, Hongmei Li, Yadong Chen, Tao Lu, Yuqin Yao, Yong Zhu	9
11	Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy breakdown → 2021 ·Frontiers in Cell and Developmental Biology ·Zui Tan, Hongbao Sun, Taixiong Xue, Cailing Gan, Hongyao Liu, Yuting Xie, Yuqin Yao, Tinghong Ye	153
12	Multi‐technical analysis on the antioxidative capacity and total phenol contents of 94 traditional Chinese dietary medicinal herbs 2018 ·Food Science & Nutrition ·(unknown), Jiayi Chen, (unknown), Yun Leng, (unknown), Pengwei Hu, Yuqin Yao, Jingyuan Xiong, Xiaofang Pei	10
13	Comparative RNA‐Seq transcriptome analysis on silica induced pulmonary inflammation and fibrosis in mice silicosis model 2018 ·Journal of Applied Toxicology ·Jiayi Chen, Yuqin Yao, Xiaolan Su, (unknown), Xuejiao Song, Linshen Xie, Jia You, (unknown), Luo Yang, Aiping Fang, Jingyuan Xiong	21
14	Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption 2018 ·Nutrition and Cancer ·Xuejiao Song, Tiantao Gao, Qian Lei, Lidan Zhang, Yuqin Yao, Jingyuan Xiong	35
15	Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST) 2017 ·World Journal of Surgical Oncology ·(unknown), Yuan Yin, Chaoyong Shen, (unknown), Xiaonan Yin, Bo Zhang, Yuqin Yao, Jinliang Yang, Zhi‐Xin Chen	16
16	Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer 2017 ·Signal Transduction and Targeted Therapy ·Hang Zhang, Yuxi Wang, Yangping Wu, Xiaohua Jiang, Yiran Tao, Yuqin Yao, Yujia Peng, Xi Chen, (unknown), Lin Yu, Ruixue Wang, Qinhuai Lai, (unknown), Wenting Li, (unknown), (unknown), Ying Lu, Lantu Gou, Min Wu, Jinliang Yang	32
17	Synthesis, characterization and targeting chemotherapy for ovarian cancer of trastuzumab-SN-38 conjugates 2015 ·Journal of Controlled Release ·Yuqin Yao, Lin Yu, Xiaolan Su, Yuxi Wang, Wenting Li, (unknown), (unknown), Hang Zhang, (unknown), Hao Chen, Rundong Zhang, Lantu Gou, Xiaoxin Chen, Yongmei Xie, Bo Zhang, Yonghui Zhang, Jinliang Yang, Yuquan Wei	34
18	Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model 2014 ·International Journal of Gynecological Cancer ·Yu Lin, Yuxi Wang, Yuqin Yao, Wenting Li, Qinhuai Lai, Jun Li, Yongjun Zhou, Tai‐Ran Kang, Yongmei Xie, Yangping Wu, Xi Chen, Yi Cheng, Lantu Gou, Jinliang Yang	27
19	Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling 2012 ·Journal of Molecular Medicine ·Xi Chen, Yangping Wu, Yangfu Jiang, Yan Zhou, Yuxi Wang, Yuqin Yao, (unknown), Lantu Gou, Jinliang Yang	30
20	Proteomic analysis of the interleukin‐4 (IL‐4) response in hepatitis B virus‐positive human hepatocelluar carcinoma cell line HepG2.2.15 2011 ·Electrophoresis ·Yuqin Yao, Jiong Li, (unknown), Aiping Tong, Wei Wang, Xiaolan Su, Yan Zhou, Bo Mu, Shijie Zhou, (unknown), Lijuan Chen, Lantu Gou, Hongbing Song, Jinliang Yang, Yuquan Wei	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuping Yin Breakdown of academic impact, for papers by Huan Deng Breakdown of academic impact, for papers by Shu‐Chi Wang Breakdown of academic impact, for papers by Aya Naiki‐Ito Breakdown of academic impact, for papers by Meng Xia Breakdown of academic impact, for papers by Changqing Yang Breakdown of academic impact, for papers by Ye Cheng Breakdown of academic impact, for papers by Desong Kong